Lauranne Piron
Overview
Explore the profile of Lauranne Piron including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
470
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Piron L, Cassinotto C, Guiu B
Presse Med
. 2019 Nov;
48(10):1156-1168.
PMID: 31672452
Interventional radiology (IR) has considerably grown since the 90s and has currently a central position in the management of patients suffering from cancer. The aim of this paper is to...
12.
Guiu B, Colombat S, Piron L, Hermida M, Allimant C, Pierredon-Foulongne M, et al.
Cancers (Basel)
. 2019 Jul;
11(7).
PMID: 31311170
To describe the responses, toxicities and outcomes of HCC patients treated by transarterial chemoembolization (TACE) using idarubicin-loaded TANDEM beads. Seventy-two consecutive patients (mean age: 71 years (58-84 years)) with HCC...
13.
Piron L, Le Roy J, Cassinotto C, Delicque J, Belgour A, Allimant C, et al.
Cardiovasc Intervent Radiol
. 2019 Jun;
42(11):1609-1618.
PMID: 31222382
Introduction: Cone-beam computed tomography (CBCT) has been developed to improve reliability of many interventional radiology (IR) procedures performed with Angio system, such as transarterial chemoembolization (TACE). Angio-CT has emerged as...
14.
Delicque J, Guiu B, Boulin M, Schwanz H, Piron L, Cassinotto C
Future Oncol
. 2018 Jun;
14(26):2761-2772.
PMID: 29953255
Transarterial chemoembolization (TACE) combines intra-arterial delivery of a chemotherapeutic agent with selective embolization to obtain a synergistic effect. TACE is recognized as the standard treatment of hepatocellular carcinoma patients at...
15.
Hermida M, Cassinotto C, Piron L, Assenat E, Pageaux G, Escal L, et al.
Int J Hyperthermia
. 2018 Jun;
35(1):90-96.
PMID: 29923441
Introduction: The targeting of hepatocellular carcinomas (HCC) in the hepatic dome can be challenging during percutaneous thermal ablation (PTA). The aims of this study were (1) to evaluate the safety...
16.
Cassinotto C, Denys A, Gay F, Duran R, Hocquelet A, Piron L, et al.
Cardiovasc Intervent Radiol
. 2018 Feb;
41(6):905-911.
PMID: 29484466
Purpose: The "oven effect" theory assumes that radiofrequency ablation (RFA) would be more efficient on tumors of cirrhotic livers. The aim of the study was to compare the size and...
17.
Guiu B, Jouve J, Schmitt A, Minello A, Bonnetain F, Cassinotto C, et al.
J Hepatol
. 2018 Feb;
68(6):1163-1171.
PMID: 29427728
Background & Aims: Idarubicin shows high cytotoxicity against hepatocellular carcinoma (HCC) cells, a high hepatic extraction ratio, and high lipophilicity leading to stable emulsions with lipiodol. A dose-escalation phase I...
18.
Schembri V, Cassinotto C, Panaro F, Delicque J, Pierredon M, Piron L, et al.
Cardiovasc Intervent Radiol
. 2018 Feb;
41(5):804-810.
PMID: 29388020
Purpose: The hepatic vein access during transjugular intrahepatic portosystemic shunt (TIPS) can be challenging in liver transplant recipient patients, especially when piggyback anastomosis was performed. We described a modified technique...
19.
Deshayes E, Schadde E, Piron L, Quenet F, Guiu B
J Gastrointest Surg
. 2017 Aug;
21(10):1754-1755.
PMID: 28785933
No abstract available.
20.
Piron L, Deshayes E, Escal L, Souche R, Herrero A, Pierredon-Foulongne M, et al.
Bull Cancer
. 2017 May;
104(5):407-416.
PMID: 28477870
Portal vein embolization consists of occluding a part of the portal venous system in order to achieve the hypertrophy of the non-embolized liver segments. This technique is used during the...